<optgroup id="eskm2"><optgroup id="eskm2"></optgroup></optgroup>
<nav id="eskm2"><code id="eskm2"></code></nav>
  • <xmp id="eskm2"><menu id="eskm2"></menu>
    <menu id="eskm2"><menu id="eskm2"></menu></menu>
    <nav id="eskm2"><strong id="eskm2"></strong></nav>
    <input id="eskm2"></input>
  • <menu id="eskm2"><strong id="eskm2"></strong></menu>
    <menu id="eskm2"></menu>
  • 福大首頁| 會議室預約|

    師資隊伍

    生物醫學工程系

    當前位置: 首頁 -> 師資隊伍 -> 教學單位
    • 徐楊愷

      性別:男

      學歷:博士研究生

      電子郵件:xuyk@fzu.edu.cn

      研究方向:1.心腦血管疾病機制解析與治療策略探索; 2.結合新型材料與技術開展轉化醫學研究。

      研究生招生專業:生物醫學工程(學碩)、生物技術與工程(專碩)

    • 詳細資料

      教育工作經歷:

      2024.11-至今:福州大學,生物科學與工程學院,副教授;

      2020.09-2024.10:北京大學,病理生理學,博士

      2015.09-2020.07:北京大學,基礎醫學,本科。

      教學簡介:

      本科生課程:

      研究生課程:

      科研簡介:

      作為參與作者在European Heart Journal、Signal Transduction And Targeted Therapy、Neuron、Advanced Science等期刊發表論文10篇,并參與撰寫專著HDL Metabolism and Diseases。主要研究方向為:1.心腦血管疾病機制解析與治療策略探索;2.結合新型材料與技術開展轉化醫學研究。

      聚焦心腦血管疾病的關鍵病理機制與創新治療策略,通過多尺度解析(分子-細胞-器官-系統)與多模態技術融合(單細胞測序、多組學分析、藥物庫篩選、光動力治療等),深入探索血管內皮穩態失衡、血栓動態演化及神經-免疫代謝網絡跨器官調控的核心規律,構建從基礎發現到臨床轉化的全鏈條研究體系,致力于突破主動脈瘤、動脈粥樣硬化及腦卒中等重大疾病的診療瓶頸,研究成果旨在應用于個體化篩查及預防方案,降低心腦血管事件發病率并改善患者預后。

      主持科研項目:

      代表性論文:

      Gao J, Cao H, Hu G, Wu Y, Xu Y, Cui H, Lu HS, Zheng L. The mechanism and therapy of aortic aneurysms. Signal Transduct Target Ther. 2023 Feb 3;8(1):55.(IF 40.9,Q1)

      Fang L, Liu C, Jiang ZZ, Wang M, Geng K, Xu Y, Zhu Y, Fu Y, Xue J, Shan W, Zhang Q, Chen J, Chen J, Zhao M, Guo Y, Siu KWM, Chen YE, Xu Y, Liu D, Zheng L. Annexin A1 binds PDZ and LIM domain 7 to inhibit adipogenesis and prevent obesity. Signal Transduct Target Ther. 2024 Aug 23;9(1):218.(IF 40.9,Q1)

      Cui H, Chen Y, Li K, Zhan R, Zhao M, Xu Y, Lin Z, Fu Y, He Q, Tang PC, Lei I, Zhang J, Li C, Sun Y, Zhang X, Horng T, Lu HS, Chen YE, Daugherty A, Wang D, Zheng L. Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection. Eur Heart J. 2021 Nov 7;42(42):4373-4385.(IF 37.6,Q1)

      Ge X, Cui H, Kong J, Lu SY, Zhan R, Gao J, Xu Y, Lin S, Meng K, Zu L, Guo S, Zheng L. A Non-Invasive Nanoprobe for In Vivo Photoacoustic Imaging of Vulnerable Atherosclerotic Plaque. Adv Mater. 2020 Sep;32(38):e2000037.(IF 27.3,Q1)

      Zhan R, Meng X, Tian D, Xu J, Cui H, Yang J, Xu Y, Shi M, Xue J, Yu W, Hu G, Li K, Ge X, Zhang Q, Zhao M, Du J, Guo X, Xu W, Gao Y, Yao C, Chen F, Chen Y, Shan W, Zhu Y, Ji L, Pan B, Yu Y, Li W, Zhao X, He Q, Liu X, Huang Y, Liao S, Zhou B, Chui D, Chen YE, Sun Z, Dong E, Wang Y, Zheng L. NAD+ rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis. Neuron. 2023 Aug 29:S0896-6273(23)00622-0.(IF 14.9,Q1)

      Gao J, Chen Y, Wang H, Li X, Li K, Xu Y, Xie X, Guo Y, Yang N, Zhang X, Ma D, Lu HS, Shen YH, Liu Y, Zhang J, Chen YE, Daugherty A, Wang DW, Zheng L. Gasdermin D Deficiency in Vascular Smooth Muscle Cells Ameliorates Abdominal Aortic Aneurysm Through Reducing Putrescine Synthesis. Adv Sci (Weinh). 2023 Feb;10(5):e2204038. (IF 14.4,Q1)

      Kong J, Yao C, Dong S, Wu S, Xu Y, Li K, Ji L, Shen Q, Zhang Q, Zhan R, Cui H, Zhou C, Niu H, Li G, Sun W, Zheng L. ICAM-1 Activates Platelets and Promotes Endothelial Permeability through VE-Cadherin after Insufficient Radiofrequency Ablation. Adv Sci (Weinh). 2021 Jan 4;8(4):2002228. (IF 14.4,Q1)

      Li J, Chen Y, Gao J, Chen Y, Zhou C, Lin X, Liu C, Zhao M, Xu Y, Ji L, Jiang Z, Pan B, Zheng L. Eva1a ameliorates atherosclerosis by promoting re-endothelialization of injured arteries via Rac1/Cdc42/Arpc1b. Cardiovasc Res. 2021 Jan 21;117(2):450-461. (IF 10.1,Q1)

      Li C, Zhao M, Xiao L, Wei H, Wen Z, Hu D, Yu B, Sun Y, Gao J, Shen X, Zhang Q, Cao H, Huang J, Huang W, Li K, Huang M, Ni L, Yu T, Ji L, Xu Y, Liu G, Konerman MC, Zheng L, Wen Wang D. Prognostic Value of Elevated Levels of Plasma N-Acetylneuraminic Acid in Patients With Heart Failure. Circ Heart Fail. 2021 Nov;14(11):e008459.(IF 7.8,Q1)

      Fan X, Li K, Guo X, Liao S, Zhang Q, Xu Y, Cui H, Zheng L, Xu M. Metabolic profiling reveals altered tryptophan metabolism in patients with kawasaki disease. Front Mol Biosci. 2023 May 4;10:1180537.(IF 3.9,Q2)

      Zheng L. HDL Metabolism and Diseases. Spring Nature, 2022, Volume 1377. (編輯撰寫其中兩個章節HDL Structure和HDL and Endothelial Function)

      授權專利情況:

      獲獎情況:

      其他

    人体色图